Securian Asset Management Inc increased its position in Colgate-Palmolive (NYSE:CL) by 0.7% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 89,037 shares of the company’s stock after purchasing an additional 636 shares during the period. Securian Asset Management Inc’s holdings in Colgate-Palmolive were worth $5,299,000 at the end of the most recent quarter.
Other institutional investors have also recently bought and sold shares of the company. Vanguard Group Inc. increased its position in Colgate-Palmolive by 1.0% in the 3rd quarter. Vanguard Group Inc. now owns 73,520,894 shares of the company’s stock valued at $4,922,224,000 after acquiring an additional 734,860 shares during the period. Vanguard Group Inc increased its position in Colgate-Palmolive by 1.0% in the 3rd quarter. Vanguard Group Inc now owns 73,520,894 shares of the company’s stock valued at $4,922,224,000 after acquiring an additional 734,860 shares during the period. Bank of New York Mellon Corp increased its position in Colgate-Palmolive by 1.1% in the 3rd quarter. Bank of New York Mellon Corp now owns 20,359,199 shares of the company’s stock valued at $1,363,050,000 after acquiring an additional 223,814 shares during the period. Morgan Stanley increased its position in Colgate-Palmolive by 15.0% in the 3rd quarter. Morgan Stanley now owns 7,212,524 shares of the company’s stock valued at $482,879,000 after acquiring an additional 941,008 shares during the period. Finally, Franklin Resources Inc. increased its position in Colgate-Palmolive by 0.8% in the 3rd quarter. Franklin Resources Inc. now owns 4,790,397 shares of the company’s stock valued at $320,717,000 after acquiring an additional 37,145 shares during the period. 75.21% of the stock is owned by institutional investors and hedge funds.
In related news, Director John T. Cahill sold 5,780 shares of the company’s stock in a transaction that occurred on Thursday, January 31st. The stock was sold at an average price of $64.46, for a total value of $372,578.80. Following the sale, the director now owns 27,820 shares of the company’s stock, valued at approximately $1,793,277.20. The transaction was disclosed in a filing with the SEC, which is available through this link. 1.02% of the stock is currently owned by corporate insiders.
Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, January 25th. The company reported $0.74 earnings per share for the quarter, topping analysts’ consensus estimates of $0.73 by $0.01. Colgate-Palmolive had a return on equity of 25,268.29% and a net margin of 15.44%. The business had revenue of $3.81 billion for the quarter, compared to analysts’ expectations of $3.78 billion. During the same quarter in the prior year, the firm posted $0.75 EPS. The company’s revenue was down 2.1% compared to the same quarter last year. Analysts expect that Colgate-Palmolive will post 2.83 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Friday, February 15th. Investors of record on Wednesday, January 23rd will be paid a $0.42 dividend. This represents a $1.68 dividend on an annualized basis and a yield of 2.54%. The ex-dividend date is Tuesday, January 22nd. Colgate-Palmolive’s payout ratio is currently 56.57%.
Several equities analysts recently issued reports on CL shares. UBS Group set a $71.00 price target on Colgate-Palmolive and gave the company a “buy” rating in a research report on Wednesday, October 17th. Argus dropped their target price on Colgate-Palmolive from $75.00 to $70.00 and set a “buy” rating on the stock in a research report on Tuesday, October 30th. Goldman Sachs Group upgraded Colgate-Palmolive from a “neutral” rating to a “buy” rating in a research report on Tuesday, January 8th. Zacks Investment Research upgraded Colgate-Palmolive from a “sell” rating to a “hold” rating in a research report on Thursday, January 10th. Finally, Morgan Stanley dropped their target price on Colgate-Palmolive from $65.00 to $60.00 and set a “hold” rating on the stock in a research report on Tuesday, October 30th. Two equities research analysts have rated the stock with a sell rating, thirteen have given a hold rating and three have issued a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of $65.13.
ILLEGAL ACTIVITY WARNING: This piece of content was first published by Community Financial News and is the property of of Community Financial News. If you are viewing this piece of content on another site, it was copied illegally and reposted in violation of US and international copyright laws. The legal version of this piece of content can be read at https://www.com-unik.info/2019/02/13/securian-asset-management-inc-boosts-stake-in-colgate-palmolive-cl.html.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products.
Read More: No Load Funds
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.